Goldman Sachs’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,658
Closed -$15K 4880
2024
Q1
$15K Buy
1,658
+305
+23% +$2.76K ﹤0.01% 4628
2023
Q4
$14.9K Sell
1,353
-203
-13% -$2.23K ﹤0.01% 4627
2023
Q3
$27.6K Sell
1,556
-818
-34% -$14.5K ﹤0.01% 4536
2023
Q2
$130K Buy
2,374
+269
+13% +$14.8K ﹤0.01% 4516
2023
Q1
$143K Buy
2,105
+606
+40% +$41.3K ﹤0.01% 4610
2022
Q4
$90.8K Buy
1,499
+304
+25% +$18.4K ﹤0.01% 4698
2022
Q3
$120K Sell
1,195
-700
-37% -$70.3K ﹤0.01% 4876
2022
Q2
$167K Buy
1,895
+1,124
+146% +$99.1K ﹤0.01% 4958
2022
Q1
$117K Buy
771
+360
+88% +$54.6K ﹤0.01% 5264
2021
Q4
$131K Buy
+411
New +$131K ﹤0.01% 5145
2021
Q3
Sell
-9,078
Closed -$2.72M 5502
2021
Q2
$2.72M Sell
9,078
-5,255
-37% -$1.57M ﹤0.01% 3266
2021
Q1
$4.27M Buy
14,333
+1,666
+13% +$497K ﹤0.01% 2781
2020
Q4
$3.86M Buy
+12,667
New +$3.86M ﹤0.01% 2631